云顶yd2223线路检测(中国)有限公司
ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Focus
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
CONTACT
中文
|
EN
ABOUT SIMR
Company Profile
Management Team
SAB
Vision & Mission
Milestones
Investors
R&D
Research Focus
Pipeline
Translational Center
MEDIA
Expanded Access Policy
Press Releases
PARTNER
Business Development
Research Cooperation
JOIN US
CONTACT
中文
EN
Expanded Access Policy
Press Releases
Home
>
MEDIA
MEDIA
Expanded Access Policy
Press Releases
16
2024-09
First Patient Enrolled in Phase 2 Clinical Trial of SR750 fo
Shanghai, China – [September 16th, 2024] – SIMR Biotech announces the enrollment...
12
2026-01
Milestone | SR2162 Receives IND Approval
Shanghai, China – [November 10th, 2025] – Shanghai SIMR Biotechnology Co., Ltd. ...
11
2025-04
SIMR Biotech to Present Phase Ib Data of SR1375 in Pneumonia
April 11, 2025 | Shanghai - SIMR Biotech today announced that it will present ne...
11
2025-04
SIMR Biotech to Deliver Oral Presentation on Novel DKD Treat
April 11, 2025 | Shanghai — SIMR Biotech announced today that its abstract title...
11
2025-04
SIMR Biotech to Present Novel Lp-PLA2 Inhibitor SR1375 for D
April 11, 2025 | Shanghai — SIMR Biotech announced today that its abstract title...
11
2024-09
First Patient Enrolled in Phase 2 Clinical Trial of SR1375 i
On 11th September 2024, Shanghai SIMR Biotechnology Co., Ltd. announced that the...
Home
Previous
1
2
3
4
Next
Last
Previous
Next
Road
4
page
23
strip
